Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Evaluation of safety profile, pharmacokinetics, and clinical benefit of an innovative terbinafine transungual solution (P-3058): A phase I study in patients with mild-to-moderate distal subungual onychomycosis
  1. Home
  2. Publications
  3. Evaluation of safety profile, pharmacokinetics, and clinical benefit of an innovative terbinafine transungual solution (P-3058): A phase I study in patients with mild-to-moderate distal subungual onychomycosis

Evaluation of safety profile, pharmacokinetics, and clinical benefit of an innovative terbinafine transungual solution (P-3058): A phase I study in patients with mild-to-moderate distal subungual onychomycosis


Publisher website
Google Scholar
  • 1 April 2013
    • journal article
    • Published by Elsevier in Journal of the American Academy of Dermatology
    • Vol. 68  (4) , AB105
    • DOI:10.1016/j.jaad.2012.12.435
Abstract
No abstract available
Keywords
  • SAFETY
  • PHARMACOKINETICS
  • ONYCHOMYCOSIS
  • TERBINAFINE TRANSUNGUAL
  • TRANSUNGUAL SOLUTION
  • INNOVATIVE TERBINAFINE
  • MODERATE DISTAL
Cited by 1 article
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.